Detailed information for compound 1759218

Basic information

Technical information
  • TDR Targets ID: 1759218
  • Name: N-cyclohexyl-1H-indole-2-carboxamide
  • MW: 242.316 | Formula: C15H18N2O
  • H donors: 2 H acceptors: 1 LogP: 3.47 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C(c1cc2c([nH]1)cccc2)NC1CCCCC1
  • InChi: 1S/C15H18N2O/c18-15(16-12-7-2-1-3-8-12)14-10-11-6-4-5-9-13(11)17-14/h4-6,9-10,12,17H,1-3,7-8H2,(H,16,18)
  • InChiKey: MSEFNSIAEMAOPJ-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • ZINC07916535

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Brugia malayi Lipase family protein 0.2141 0.3589 1
Loa Loa (eye worm) hypothetical protein 0.0381 0.0491 0.1254
Leishmania major hypothetical protein, conserved 0.0314 0.0373 0.0919
Trypanosoma cruzi Alpha/beta hydrolase family, putative 0.0314 0.0373 0.0919
Trypanosoma cruzi hypothetical protein, conserved 0.2141 0.3589 1
Loa Loa (eye worm) lipase 0.2141 0.3589 1
Echinococcus granulosus abhydrolase domain containing protein 11 0.0381 0.0491 0.1254
Echinococcus granulosus sn1 specific diacylglycerol lipase beta 0.2141 0.3589 1
Plasmodium vivax alpha/beta hydrolase, putative 0.0381 0.0491 0.5
Echinococcus multilocularis sn1 specific diacylglycerol lipase beta 0.2141 0.3589 1
Toxoplasma gondii hydrolase, alpha/beta fold family protein 0.0314 0.0373 1
Mycobacterium tuberculosis Probable oxidoreductase 0.012 0.0031 0.0031
Wolbachia endosymbiont of Brugia malayi esterase 0.0129 0.0047 0.5
Trypanosoma cruzi Alpha/beta hydrolase family, putative 0.0314 0.0373 0.0919
Plasmodium falciparum alpha/beta hydrolase, putative 0.0381 0.0491 0.5
Mycobacterium tuberculosis Probable oxidoreductase 0.0626 0.0923 0.0939
Echinococcus multilocularis abhydrolase domain containing protein 11 0.0381 0.0491 0.1254
Trypanosoma brucei Alpha/beta hydrolase family, putative 0.0314 0.0373 0.0919
Mycobacterium tuberculosis Probable haloalkane dehalogenase 0.012 0.0031 0.0031
Mycobacterium ulcerans short chain dehydrogenase 0.0626 0.0923 0.0923
Trypanosoma brucei lipase domain protein, putative 0.2141 0.3589 1
Mycobacterium tuberculosis Possible hydrolase 0.0314 0.0373 0.0379
Trypanosoma brucei lipase domain protein, putative 0.2141 0.3589 1
Chlamydia trachomatis lysophospholipase esterase 0.0129 0.0047 0.5
Mycobacterium tuberculosis Conserved protein 0.012 0.0031 0.0031
Trichomonas vaginalis lipase containing protein, putative 0.2141 0.3589 0.5
Trichomonas vaginalis lipase containing protein, putative 0.2141 0.3589 0.5
Brugia malayi hydrolase, alpha/beta fold family protein 0.0314 0.0373 0.0919
Leishmania major hypothetical protein, conserved 0.2141 0.3589 1
Schistosoma mansoni family S33 non-peptidase homologue (S33 family) 0.0381 0.0491 1
Mycobacterium leprae Possible short-chain dehydrogenase EphD 0.0102 0 0.5
Mycobacterium tuberculosis 4,9-DHSA hydrolase 0.569 0.9836 1
Trypanosoma cruzi hypothetical protein, conserved 0.2141 0.3589 1
Mycobacterium tuberculosis Possible haloalkane dehalogenase 0.012 0.0031 0.0031
Mycobacterium ulcerans hydrolase 0.0314 0.0373 0.0373
Onchocerca volvulus 0.2141 0.3589 0.5

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.